DOMO:NASDAQDomo, Inc. Analysis
Data as of 2026-03-29 - not real-time
$3.10
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Domo, Inc. (DOMO) is trading at $3.10, well below its 20‑day ($3.99) and 50‑day ($4.63) simple moving averages, with the price sitting near the identified support of $3.06 and far under the DCF‑derived fair value of $16.76, suggesting a substantial upside potential. The RSI of 33 points to oversold conditions, while a bearish MACD histogram reinforces short‑term downside pressure, and the stock’s 30‑day volatility exceeds 110% with a beta of 1.68, indicating a highly volatile, high‑beta profile.
On the fundamentals side, Domo posted record quarterly billings of $111.2 million (up 8% YoY) and improved retention, yet it still reports negative operating margins (‑9%) and a trailing EPS of –$1.45, though forward EPS is projected at $0.14. The company announced a new partnership with Nine Entertainment and a major product upgrade, and it is actively exploring strategic alternatives to unlock value. Despite a modest revenue growth of 1.1% and a negative book value per share, free cash flow is positive at $57 million, and analysts maintain a “buy” consensus with median price targets around $7, highlighting the perceived valuation gap.
On the fundamentals side, Domo posted record quarterly billings of $111.2 million (up 8% YoY) and improved retention, yet it still reports negative operating margins (‑9%) and a trailing EPS of –$1.45, though forward EPS is projected at $0.14. The company announced a new partnership with Nine Entertainment and a major product upgrade, and it is actively exploring strategic alternatives to unlock value. Despite a modest revenue growth of 1.1% and a negative book value per share, free cash flow is positive at $57 million, and analysts maintain a “buy” consensus with median price targets around $7, highlighting the perceived valuation gap.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering at technical support with oversold RSI
- Bearish MACD and decreasing volume indicating downside pressure
- Recent partnership and product upgrade could provide short‑term catalyst
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation upside versus DCF fair value
- Record billings and improving retention suggest revenue momentum
- Exploration of strategic alternatives may unlock shareholder value
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Long‑term demand for AI‑driven data platforms in enterprise markets
- Positive free cash flow despite negative earnings
- Analyst consensus and price targets indicating upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth1.10%
Profit Margin-18.61%
P/E Ratio22.8
ROA-9.98%
P/B Ratio-0.7
Op. Cash Flow$7.9M
Free Cash Flow$57.2M
Industry P/E32.0
Technical Analysis
TrendBearish
RSI33.3
Support$3.06
Resistance$6.24
MA 20$3.99
MA 50$4.63
MA 200$11.09
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98
Valuation
Fair Value$16.76
Target Price$6.20
Upside/Downside100.00%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.68
Volatility112.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.